BioCryst Appoints David W. Jenkins as Chief Scientific Officer
Go back to BioCryst Appoints David W. Jenkins as Chief Scientific Officer| BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) | Delayed: 8.81 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.81 | 52 Week High | $10.98 | |||
| Open | $8.81 | 52 Week Low | $1.63 | |||
| Day High | $8.81 | P/E | N/A | |||
| Day Low | $8.81 | EPS | $-0.68 | |||
| Volume | 7,340 | |||||
